| pubmed-article:21366807 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C0022359 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C0012544 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:21366807 | lifeskim:mentions | umls-concept:C2267018 | lld:lifeskim |
| pubmed-article:21366807 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21366807 | pubmed:dateCreated | 2011-4-7 | lld:pubmed |
| pubmed-article:21366807 | pubmed:abstractText | Bone-destructive disease treatments include bisphosphonates and antibodies against receptor activator for nuclear factor ?B ligand (aRANKL). Osteonecrosis of the jaw (ONJ) is a side-effect. Aetiopathology models failed to explain their restriction to the jaw. The osteoproliferative transcription factor Msx-1 is expressed constitutively only in mature jaw bone. Msx-1 expression might be impaired in bisphosphonate-related ONJ. This study compared the expression of Msx-1, Bone Morphogenetic Protein (BMP)-2 and RANKL, in ONJ-affected and healthy jaw bone. | lld:pubmed |
| pubmed-article:21366807 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21366807 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21366807 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21366807 | pubmed:month | May | lld:pubmed |
| pubmed-article:21366807 | pubmed:issn | 1601-0825 | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:AmanoHH | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:HyckelPP | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:RiesJJ | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:StockmannPP | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:NkenkeEE | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:WehrhanFF | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:SchlegelKaK | lld:pubmed |
| pubmed-article:21366807 | pubmed:author | pubmed-author:NeukamFwF | lld:pubmed |
| pubmed-article:21366807 | pubmed:copyrightInfo | © 2011 John Wiley & Sons A/S. | lld:pubmed |
| pubmed-article:21366807 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21366807 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:21366807 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21366807 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21366807 | pubmed:pagination | 433-42 | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:meshHeading | pubmed-meshheading:21366807... | lld:pubmed |
| pubmed-article:21366807 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21366807 | pubmed:articleTitle | Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment. | lld:pubmed |
| pubmed-article:21366807 | pubmed:affiliation | Department of Oral and Maxillofacial Surgery, University of Erlangen-Nuremberg, Erlangen, Germany. falk.wehrhan@uk-erlangen.de | lld:pubmed |
| pubmed-article:21366807 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21366807 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:21366807 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:4487 | entrezgene:pubmed | pubmed-article:21366807 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21366807 | lld:entrezgene |
